Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Deferred Revenue: 2015-2019

Historic Current Deferred Revenue for CorMedix (CRMD) over the last 5 years, with Dec 2019 value amounting to $2,206.

  • CorMedix's Current Deferred Revenue fell 80.00% to $2,206 in Q4 2019 from the same period last year, while for Dec 2019 it was $2,206, marking a year-over-year decrease of 80.00%. This contributed to the annual value of $2,206 for FY2019, which is 80.00% down from last year.
  • Latest data reveals that CorMedix reported Current Deferred Revenue of $2,206 as of FY2019, which was down 80.00% from $11,029 recorded in FY2018.
  • CorMedix's 5-year Current Deferred Revenue high stood at $130,409 for FY2015, and its period low was $2,206 during FY2019.
  • Its 3-year average for Current Deferred Revenue is $33,880, with a median of $11,029 in 2018.
  • Data for CorMedix's Current Deferred Revenue shows a maximum YoY plummeted of 87.52% (in 2018) over the last 5 years.
  • CorMedix's Current Deferred Revenue (Yearly) stood at $130,409 in 2015, then dropped by 20.09% to $104,210 in 2016, then declined by 15.17% to $88,404 in 2017, then tumbled by 87.52% to $11,029 in 2018, then crashed by 80.00% to $2,206 in 2019.